Humphrey Rachel
Pyxis Oncology, Inc. · Director
Humphrey Rachel is listed in filings as Director at Pyxis Oncology, Inc.. This profile follows SEC Form 4 activity through Mar 25, 2026, including sale activity. Recent filings connect the profile to Pyxis Oncology, Inc. (PYXS). The current snapshot covers public activity from Apr 2, 2025 to Mar 25, 2026. Reported amounts are shown as $62.4K to $194. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $14k13.9k shares | SellApr 21, 2025 | $1.03 | $2.36 |